Browsing items tagged “biosimilar | EVERSANA”

Australian Biosimilars Association Hosts Successful Awareness Week, Plans Webinar

Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #awareness #biosimilars #education #gbma #webinar PRICENTRIC BRIEF: In May, GBMA Education, the educational arm of Australia’s Generic and Biosimilar Medicines Association (GBMA), hosted its second Biosimilar Awareness Week, which included online activities and the dissemination of online information to over 540,000 Australians on biosimilars and their crucial role “in the future of a sustainable healthcare […]

Biosimilars Saved Spain 2,400 Million Euros Between 2009 and 2020

Country: SPAIN | Region: EUROPE | Type: Biosimilar | Keywords: #inflammatorydiseases #monoclonalantibodies #oncology #regulation #sefh PRICENTRIC BRIEF: The Spanish Society of Hospital Pharmacists (SEFH) calculated that Spain has saved more than 2,400 million euros between 2009 and 2020 through the introduction of biosimilars for the treatment of inflammatory diseases and cancer In the article, published in the May/June issue of the journal Farmacia Hospitalaria, Dr. Miguel Ángel Calleja, former […]

FDA Publishes Final Rule on New Regulatory Pathway Shift for Insulin, Other Biologics

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #biologicdrugs #biosimilar #fda #insulin #regulation PRICENTRIC BRIEF: On March 23, 2020, an application for a biological product approved under the Federal Food, Drug, and Cosmetic Act (FD&C Act), including applications for insulin and other biological products, will be deemed to be a license for the product under the Public Health Service (PHS) Act For the first […]